Loading...

Mogamulizumab for the treatment of cutaneous T-cell lymphoma: recent advances and clinical potential

Mogamulizumab (KW-0761) is a humanized immunoglobulin G1 (IgG1) monoclonal antibody (mAb) that targets CC chemokine receptor 4 (CCR4). It has shown promising therapeutic potential in phase I and II clinical trials and is currently being investigated for efficacy in treating cutaneous T-cell lymphoma...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ther Adv Hematol
Main Authors: Duvic, Madeleine, Evans, Mark, Wang, Casey
Format: Artigo
Sprog:Inglês
Udgivet: SAGE Publications 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4872175/
https://ncbi.nlm.nih.gov/pubmed/27247757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620716636541
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!